CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$14.13
+0.11%
Mkt Cap $856.08M
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
Implied Upside
+53.4%
Consensus $21.67 vs current $14.13
NASDAQ·Healthcare·Biotechnology
$14.13
+0.11%
Mkt Cap $856.08M
Buy
18
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
+53.4%
Consensus $21.67 vs current $14.13